OCC 1.37% 37.0¢ orthocell limited

Without blatantly cross-referencing, I am also a shareholder in...

  1. 1,316 Posts.
    lightbulb Created with Sketch. 263
    Without blatantly cross-referencing, I am also a shareholder in PAR. They are currently doing a trial with a dozen retired NFL players with their Osteoarthritis drug. It's a very clever strategy, because these guinea pigs, so to speak, aren't your average Joe. Successful outcomes will get widespread media attention in the U.S. and it all takes off from there. You can't go out and buy that publicity. If the results are successful, and they should be, the media frenzy follows...for free! It's brilliant marketing.

    This is the type of trial OCC need to do ASAP! Pro sports careers are ended with these injuries. The window of opportunity is right there, so why are shareholders the only ones who can see it?!
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
37.0¢
Change
0.005(1.37%)
Mkt cap ! $77.54M
Open High Low Value Volume
37.5¢ 37.5¢ 36.3¢ $79.28K 216.6K

Buyers (Bids)

No. Vol. Price($)
2 117325 36.5¢
 

Sellers (Offers)

Price($) Vol. No.
37.0¢ 37982 2
View Market Depth
Last trade - 15.32pm 15/08/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.